University of Basel Research Reveals Immune System Actively Fights Chronic Viral Infections Contracted at Birth
New research shows the immune system battles lifelong viruses like Hepatitis B. University of Basel scientists discover T helper cells as a key therapy target.
By: AXL Media
Published: Apr 29, 2026, 6:23 AM EDT
Source: Information for this report was sourced from EurekAlert!

Challenging the Narrative of Viral Tolerance
Scientific teams at the University of Basel have uncovered evidence that the human body does not passively accept viral infections established at birth. For decades, the medical community operated under the assumption that the immune system largely ignored pathogens introduced during the perinatal period, such as the hepatitis B virus. However, according to Dr. Katrin Martin, the study indicates that the body’s defenses continue to engage the virus well into adulthood. While the immune response is described as operating with the brakes on, it achieves partial success in controlling the viral load, marking a significant shift in how chronic neonatal infections are understood.
The Role of Specialized T Helper Cells
The research utilized a sophisticated mouse model to observe the long term interactions between a developing immune system and persistent viral threats. The investigation revealed that the body gradually generates antibodies specifically designed to reduce the presence of the virus. This process is heavily dependent on T helper cells, which are responsible for coordinating the production of high quality antibodies by other immune units. According to Dr. Peter Reuther, while these cells remain functional in adult subjects who were infected at birth, they lack the diversity and frequency found in individuals who contract similar infections later in life.
Mechanisms of Limited Immune Diversity
The study suggests that the timing of the infection is the primary factor limiting the body's defensive capabilities. Because the virus is introduced during a highly sensitive phase of immune development, the production of specific T cells is naturally restricted. This results in a state of partial tolerance where the organism recognizes the pathogen but cannot mount a full scale offensive to eliminate it entirely. This biological trade off allows the virus to persist indefinitely, even though the immune system remains aware of its presence and continues to exert a level of pressure against it.
Categories
Topics
Related Coverage
- Garvan Institute Researchers Overturn Longstanding Theory on Rare Inflammatory Disease Mevalonate Kinase Deficiency
- Molecular Breakthrough at Johns Hopkins Identifies RhoA Protein as Critical Driver of Asthma Airway Inflammation
- University of Barcelona Study Identifies Polμ Protein as Vital Safeguard for Immune Cells During Severe Infection
- Boston Medical Center Simulation Warns Lower Newborn Vaccination Coverage Could Trigger Tenfold Increase in Hepatitis B Infections